BUYER DISCOVERY
Who buys medical device companies?
266 disclosed medical device companyacquisitions analyzed — the active strategic and private equity buyers, how often each one buys, and their most recent named deals. Sourced from SEC filings and verified M&A press releases.
Quick answers
- How many disclosed transactions?
- 266 disclosed medical device company acquisitions with a named acquirer.
- Most active buyers
- Boston Scientific Corporation (11) · StrykerCorp. (10) · Integra Lifesciences Holdings Corp. (7) · Medtronic plc (6) · Teleflex, Inc. (5) · Halma plc (5)
- What would these buyers pay for my business?
- Run the ExitValue.ai calculator to price your medical device company against these 266 disclosed transactions. The engine surfaces what each buyer pool pays for your size, margin, and growth profile.
Top strategic buyers
Operators, larger competitors, and corporate consolidators acquiring medical device company businesses for synergy and capability fill.
| Acquirer | Deals | Median deal size | Recent targets |
|---|---|---|---|
| Boston Scientific Corporation | 11 | $850M | Elutia BioEnvelope Business (2025), Nalu Medical, Inc. (2025), Axonics, Inc. (2024), Relievant Medsystems, Inc. (2023) |
| StrykerCorp. | 10 | $686M | Wright Medical Group N.V. (2021), Entellus Medical, Inc. (2018), Invuity (2018), K2M Group Holdings, Inc. (2018) |
| Integra Lifesciences Holdings Corp. | 7 | $248M | Surgical Innovation Associates, Inc. (DuraSorb) (2022), ACell, Inc. (2021), Codman & Shurtleff, Inc. (JNJ) (2017), Derma Sciences, Inc. (2017) |
| Medtronic plc | 6 | $1.2B | Intersect ENT, Inc. (2022), Mazor Robotics (2018), Smith & Nephew's Gynecology Business (2016), HeartWare International, Inc. (2016) |
| Teleflex, Inc. | 5 | $876M | BIOTRONIK Vascular Intervention Business (2025), Standard Bariatrics, Inc. (2022), Z-Medica (2020), NeoTract, Inc. (2017) |
| Halma plc | 5 | $89M | Rovers Medical Devices (2024), AprioMed (2023), TeDan Surgical Innovations, Inc. (et. al.) (2023), NovaBone Products (2020) |
| Integer Holdings Corp. | 4 | $142M | Precision Coating (2025), Vertical Solutions, Inc., d/b/a VSi Parylene (2025), Aran Biomedical and Proxy Biomedical (2022), Oscor Inc. (2021) |
| Merit Medical Systems, Inc. | 4 | $108M | Cook Medical Pacemaker / ICD Lead Management Portfolio (2024), EndoGastric Solutions EsophyX Z+ (2024), AngioDynamics Dialysis Product Portfolio and BioSentry Product (2023), Avanos Medical Respiratory Business (2023) |
| STERIS plc | 4 | $697M | Becton Dickinson Surgical Instrumentation (2023), Key Surgical (2020), Synergy Health plc (2014), United States Endoscopy Group, Inc. (2012) |
| LeMaitre Vascular Inc. | 4 | $16M | Artegraft Inc. (2020), CardioCel and VascuCel Biologic Patches (Admedus) (2019), Applied Medical Resources Blood Clot Business (2018), Restore Flow Allografts (2016) |
| Cardinal Health, Inc. | 4 | $1.1B | Patient Recovery (Medtronic) (2017), Cordis (JNJ) (2015), AccessClosure (2014), Futuremed Healthcare Products (2012) |
| Medline Industries, Inc. | 3 | $286M | Microtek Medical (Ecolab) (2024), Teleflex Global Respiratory (2021), NAMIC Fluid Management (AngioDynamics) (2019) |
Top private equity buyers
Private equity firms and PE-backed platforms rolling up medical device company businesses. Platform-tier buyers typically pay up for scale, clean financials, and a management layer that survives integration.
| Acquirer | Deals | Median deal size | Recent targets |
|---|---|---|---|
| Altaris Capital Partners | 2 | $587M | Intricon Corporation (2022), Analogic Corporation (2018) |
| Linden Capital Partners | 2 | $350M | RQM+ (2021), Young Innovations (2012) |
| EQT Partners | 2 | $1.8B | Clinical Innovations (2017), Ottobock SE & Co. (2017) |
| Blackstone / TPG | 1 | $18.3B | Hologic, Inc. (2025) |
| Carlyle | 1 | $3.8B | Vantive Kidney Care (Baxter) (2024) |
| Carlyle Group | 1 | $7.0B | Medtronic Monitoring / Respiratory Units (2023) |
| H.I.G. Capital | 1 | $375M | ZimVie Spine Business (2023) |
| Bain Capital | 1 | $920M | Classys, Inc. (2022) |
| Blue Wolf Capital Partners | 1 | $120M | CIVCO Radiotherapy (2021) |
| Hellman & Friedman | 1 | $1.0B | Cordis (Cardinal Health) (2021) |
Recent M&A activity
Disclosed medical device company acquisitions by year.
Methodology note
Acquirer activity reflects disclosed M&A transactions in the ExitValue.ai database, filtered to medical device company businesses with a named acquirer. Counts include deals with disclosed financials only — total transaction volume in this segment is typically 2–3x larger. The valuation engine reveals what each buyer pool pays for your specific business when you run the calculator. Full methodology
What's your medical device company worth to these acquirers?
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Engine-grounded estimate. Comparable named deals on the full results page.
More on medical devices valuations
- Value a medical devices· run the calculator
- Medical Devices median multiples· real-deal benchmarks
- Who buys medical devices businesses?· active buyers
- Who acquired Owen Mumford Holdings?· buyer profile
- How to value a medical devices· long-form guide